Hematopoietic Stem Cell Therapy In Eight Patients with Metachromatic Leukodystrophy – Relevance of Post-Transplant Medication.

Judith Böhringer(University Children's Hospital Tübingen), Ingo Müller(Universität Hamburg), Rupert Handgretinger(STZ eyetrial), B. Kustermann‐Kuhn(Boston Children's Hospital), Annika Erbacher(University Children's Hospital Tübingen), Peter Lang(STZ eyetrial), Ingeborg Krägeloh‐Mann(University Children's Hospital Tübingen), Friederike Gieseke(University Children's Hospital Tübingen), Christiane Kehrer(University Children's Hospital Tübingen), Michaela Döring(University Children's Hospital Tübingen)
Blood
November 19, 2010
10.1182/blood.v116.21.3727.3727
Cited by 1

Related Papers

Human Lymphoid and Myeloid Cell Development in NOD/LtSz- <i>scid IL2R</i> γ <i>null</i> Mice Engrafted with Mobilized Human Hemopoietic Stem Cells,
|The Journal of Immunology|2005|1.7k
Rational Extended Thermodynamics
|Springer Tracts in Natural Philosophy|1998|1.3k
Adoptive transfer of pp65-specific T cells for the treatment of chemorefractory cytomegalovirus disease or reactivation after haploidentical and matched unrelated stem cell transplantation
|Blood|2010|430
A thermodynamic theory of mixtures of fluids
|Archive for Rational Mechanics and Analysis|1968|428
Defibrotide for prophylaxis of hepatic veno-occlusive disease in paediatric haemopoietic stem-cell transplantation: an open-label, phase 3, randomised controlled trial
|The Lancet|2012|376